High cost oncology drugs without proof of added benefit are burdening health systems
DSpace/Manakin Repository
High cost oncology drugs without proof of added benefit are burdening health systems
Brinkhuis, Francine; Goettsch, Wim Gerrit; Mantel - Teeuwisse, Aukje; Bloem, Lourens T
(2024) The BMJ, volume 384
(Comment)
Download/Full Text
Embargo until August 29 2024
Keywords: Taverne, General Medicine
DOI:
https://doi.org/10.1136/bmj.q511
ISSN: 1756-1833
Publisher: BMJ Publishing Group Ltd
(Non peer reviewed)
See
more statistics
about this item